Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-06-05Clinical Trial Update: A Study Comparing Exenatide With Basal Insulin in Achieving a Target HbA1c With Minimum Weight Gain in Type 2 Diabetes Patients [Phase 3]
Phase 3 trial comparing exenatide with basal insulin to achieve target HbA1c with minimal weight gain in type 2 diabetes; results were poste…
-
CLINICAL_TRIALS trial_result · 2009-06-05Clinical Trial Update: A Study for Patients With Diabetes Mellitus (IOPA) [Phase 4]
A Phase 4 clinical trial update sponsored by Eli Lilly for patients with type 1 and type 2 diabetes; the study is completed and results were…
-
CLINICAL_TRIALS trial_result · 2009-06-04Clinical Trial Update: Insulin Glargine Plus Insulin Glulisine Multiple Daily Injections (MDI) Versus Premix Insulin Treatment in Subjects With Diabetes Mellitus (Type 1 or Type 2) [Phase 3]
Phase 3 trial comparing insulin glargine plus insulin glulisine MDI versus premixed insulin in adults with Type 1 or Type 2 diabetes; study …
-
CLINICAL_TRIALS trial_result · 2009-06-04Clinical Trial Update: A Study to Characterize Regimens of Basal Insulin Intensified With Either Symlin® or Rapid Acting Insulin in Patients With Type 2 Diabetes [Phase 4]
This Phase 4 clinical trial update studies regimens of basal insulin intensified with either Symlin (pramlintide) or rapid-acting insulin in…
-
CLINICAL_TRIALS trial_result · 2009-06-03Clinical Trial Update: Effect of Renin Angiotensin System Blockade on the Fas Antigen (CD95) and Asymmetric Dimethylarginine (ADMA) Levels in Type-2 Diabetic Patients With Proteinuria [Phase 4]
Phase 4 trial update assessing the effect of renin-angiotensin system blockade on Fas (CD95) and asymmetric dimethylarginine (ADMA) levels i…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2009-06-03FDA Approved: GLYBURIDE-METFORMIN HYDROCHLORIDE — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approves the original application for a generic glyburide/metformin hydrochloride combination tablet.
-
CLINICAL_TRIALS trial_result · 2009-06-01Clinical Trial Update: The Impact of Exercise Counseling on Exercise Behavior in People With Type 2 Diabetes: A Randomized Clinical Trial [NA]
This document reports the results of a randomized clinical trial assessing whether exercise counseling improves exercise behavior in adults …
-
CLINICAL_TRIALS trial_result · 2009-05-22Clinical Trial Update: The Use of Cilostazol in Patients With Diabetic Nephropathy [Phase 4]
Phase 4 trial update indicating completion of a study evaluating cilostazol in patients with diabetic nephropathy.
-
CLINICAL_TRIALS trial_result · 2009-05-21Clinical Trial Update: The Effectiveness of Diabetes Patient Education and Self-Management Education in Persons With Type 2 Diabetes [NA]
This completed clinical trial evaluated the effectiveness of diabetes patient education and self-management education in persons with Type 2…
-
CLINICAL_TRIALS trial_result · 2009-05-20Clinical Trial Update: Diabetes and Metabolic Postprandial Responses [NA]
This clinical trial update notes completion of a study examining postprandial metabolic responses in individuals with Type 2 diabetes and ov…
-
CLINICAL_TRIALS trial_result · 2009-05-19Clinical Trial Update: MK0431 (Sitagliptin) and Metformin Co-Administration Factorial Study in Patients With Type 2 Diabetes Mellitus (0431-036) [Phase 3]
Phase 3 trial evaluating co-administration of sitagliptin (MK0431) with metformin in adults with type 2 diabetes mellitus; results were post…
-
CLINICAL_TRIALS trial_result · 2009-05-19Clinical Trial Update: Pharmacist Assisted Medication Program Enhancing the Regulation of Diabetes [NA]
The clinical trial evaluating a pharmacist-assisted medication program for Type 2 diabetes mellitus management has completed. The update pro…
-
CLINICAL_TRIALS trial_result · 2009-05-18Clinical Trial Update: AVANDAMET Versus Metformin And Sulphonylurea In People With Poorly Controlled Type 2 Diabetes [Phase 3]
Phase 3 trial comparing AVANDAMET (rosiglitazone/metformin) against metformin and a sulphonylurea in adults with poorly controlled type 2 di…
-
CLINICAL_TRIALS trial_result · 2009-05-13Clinical Trial Update: Study of CRx-401 on Glucose Levels in Subjects With Type II Diabetes [Phase 2]
Phase 2 trial evaluating CRx-401 on glucose levels in adults with Type 2 diabetes has completed.
-
FDA approval · 2009-05-12FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for METFORMIN HYDROCHLORIDE from Aurobindo Pharma Limited, granting supplemental approval for this g…
-
CLINICAL_TRIALS trial_result · 2009-05-12Clinical Trial Update: Effects of Different Doses of Aspirin on Pathophysiological Markers in Type 2 Diabetes [NA]
A completed clinical trial update examining the effects of different aspirin doses on pathophysiological markers in individuals with type 2 …
-
CLINICAL_TRIALS research · 2009-05-12Clinical Trial Update: Can Enhanced Glycemic Control in Type II Diabetics Improve Myocardial Protection During Coronary Artery Bypass Grafting? [NA]
The document reports a clinical trial update evaluating whether enhanced glycemic control improves myocardial protection during coronary art…
-
CLINICAL_TRIALS trial_result · 2009-05-08Clinical Trial Update: Omacor for the Treatment of Vascular Dysfunction in Patients With Type 2 Diabetes Mellitus [Phase 4]
Phase 4 clinical trial evaluating Omacor for vascular dysfunction in patients with type 2 diabetes mellitus and atherosclerosis has complete…
-
FDA approval · 2009-05-07FDA Approved: NOVOLOG — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for Novo Nordisk's NovoLog (insulin aspart).
-
FDA approval · 2009-05-07FDA Approved: LEVEMIR — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for LEVEMIR (insulin detemir) submitted by Novo Nordisk.
-
CLINICAL_TRIALS trial_result · 2009-05-07Clinical Trial Update: To Evaluate 24-hr Glucose After OD vs BD AZD1656 [Phase 1]
Phase 1 study comparing 24-hour glucose responses after once-daily versus twice-daily dosing of AZD1656 in adults with Type 2 diabetes melli…
-
CLINICAL_TRIALS trial_result · 2009-05-07Clinical Trial Update: Effect of CP-778,875 on HDL-C in Subjects With Abnormal Lipid Levels and Type 2 Diabetes. [Phase 2]
Pfizer conducted a Phase 2 trial to evaluate CP-778,875 on HDL-C in adults with dyslipidemia and type 2 diabetes. The study status is comple…
-
CLINICAL_TRIALS trial_result · 2009-05-07Clinical Trial Update: To Evaluate the Response to Glucagon During Hypoglycemia [Phase 1]
AstraZeneca completed a Phase 1 trial evaluating the body's response to glucagon during hypoglycemia in people with Type 2 diabetes.
-
FDA approval · 2009-05-06FDA Approved: GLYBURIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved Teva Pharmaceuticals USA, Inc.'s supplemental application for glyburide, a generic antidiabetic medication used to treat ty…
-
FDA approval · 2009-05-05FDA Approved: CYCLOSET — Original Application (Avvisto Therapeutics LLC)
FDA approved CYCLOSET (bromocriptine mesylate) via an original NDA from Avvisto Therapeutics LLC, for the treatment of adults with type 2 di…